Concepedia
Statistics
Publications
51
Citations
5.3K
H-Index
37
Active since
1991
Affiliations
AstraZeneca (United States)(Current)
AstraZeneca (United Kingdom)
Johnson University
Erasmus MC - Sophia Children’s Hospital
Rutgers, The State University of New Jersey
Alwin G. Schuller is an author at AstraZeneca (United States) specializing in medicine, life sciences, and pharmacology.
Publications per year
1991–2025
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu, Shifeng Pan, Mindy H. Hsieh et al. · Proceedings of the National Academy of Sciences · 2013 · 835 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Adriana E. Tron, Matthew A. Belmonte, Ammar Adam et al. · Nature Communications · 2018 · 486 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout Mice
Yanxin Zhu, Michael A. King, Alwin G. Schuller et al. · Neuron · 1999 · 432 citations · Full text
Medicine, Neuroscience, Pharmacology +16
Retention of heroin and morphine–6β–glucuronide analgesia in a new line of mice lacking exon 1 of MOR–1
Alwin G. Schuller, Michael A. King, Jiwen Zhang et al. · Nature Neuroscience · 1999 · 306 citations
Nursing, Neuroscience, Pharmacology +13
Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
Amy D. Guertin, Jing Li, Yaping Liu et al. · Molecular Cancer Therapeutics · 2013 · 171 citations
Life Sciences, Molecular Biology, Oncology +17
1–5 of 51